Abstract
Aim To map current alcohol pricing policies across the European Union and United Kingdom and review the latest evidence on their effectiveness
Design Current policies were mapped using publicly available data. Evidence was systematically reviewed using a three-stage approach: a) a systematic search for published studies in PubMed and Google Scholar, b) a snowball search of grey literature and hand-searching the references of existing reviews and c) consultation with topic experts.
Setting Any appraisal or evaluation on the impact of an alcohol pricing policy in an EU or UK nation that reported alcohol consumption or health outcomes.
Participants The general population
Measurements Any reported measures of alcohol consumption or alcohol-related health outcomes.
Findings The mapping exercise found that there is substantial variation in both the levels and structures of alcohol taxation across Europe. The review found 83 studies, consisting of 34 prospective modelling studies and 49 retrospective evaluations. These came primarily from the UK and Scandinavia. The majority of studies looked at the impact of changes to alcohol taxation, although a substantial minority looked at the impacts of Minimum Unit Pricing for alcohol. Studies consistently fond that increases in taxation, or the introduction of Minimum Unit Pricing, have led to reductions in alcohol consumption and improvements in public health and, in spite of concerns about cross-border sales moderating these benefits, there is little evidence to support these concerns in practice.
Conclusion There is ample evidence to show that alcohol pricing policies can and have worked across Europe and are likely to form a key part of any effective policy approach to reduce alcohol-related harm.
Competing Interest Statement
The authors have declared no competing interest.
Funding Statement
This research was produced under the DEEP SEAS service contract (Contract No. 20177113 - Developing and Extending Evidence and Practice from the Standard European Alcohol Survey - www.deep-seas.eu) with the Health and Digital Executive Agency (HaDEA) acting under the mandate from the European Commission (DG SANTE). The information and views set out in this report are those of the author(s), and the accuracy and veracity of these are the authors responsibility. Accordingly, the information and views presented during sessions cannot be considered to reflect the views of the Commission and/or HaDEA or any other body of the European Union. The European Commission and the Agency do not accept any responsibility for use that may be made of the information contained therein.
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.
Yes
Data Availability
All data used in this study is publicly available
